IL-12 acts as an anti-apoptotic factor for CD8+ T cells by the impediment of the activation-induced cell death of CD8+CD62Lhi naïve CD8+ T cells, increased T cell homing, and has shown sustainable anti-tumor activity against mouse models of melanoma [29]. The gene discussed is CD8A; the disease is melanoma.